Comparison of dabigatran, rivaroxaban and apixaban for effectiveness and safety in atrial fibrillation; a nationwide cohort study
Peer reviewed, Journal article
Published version
View/ Open
Date
2020Metadata
Show full item recordCollections
- Artikler [5061]
- Publikasjoner fra CRIStin FHI [7531]